Zammouri J, Vatier C, Capel E, Auclair M, Storey-London C, Bismuth E, et al. Molecular and Cellular bases of Lipodystrophy syndromes. Front Endocrinol. 2021;12:803189.

Article  Google Scholar 

Garg A. Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akinci B, Meral R, Oral EA. Phenotypic and genetic characteristics of Lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities. Curr Diab Rep. 2018;18:143.

Article  PubMed  Google Scholar 

Lim K, Haider A, Adams C, Sleigh A, Savage DB. Lipodistrophy: a paradigm for understanding the consequences of overloading adipose tissue. Physiol Rev. 2021;101:907–93.

CAS  PubMed  Google Scholar 

Semple RK. EJE PRIZE 2015: how does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur J Endocrinol. 2016;174:R209–223.

Article  CAS  PubMed  Google Scholar 

Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and management of Lipodystrophy syndromes: a Multi-society Practice Guideline. J Clin Endocrinol Metab. 2016;101:4500–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2017;49:17–26.

Article  CAS  PubMed  Google Scholar 

Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes Targets Ther. 2017;10:375–83.

Article  Google Scholar 

Gonzaga-Jauregui C, Ge W, Staples J, Van Hout C, Yadav A, Colonie R, et al. Clinical and molecular prevalence of Lipodystrophy in an unascertained large clinical care cohort. Diabetes. 2020;69:249–58.

Article  CAS  PubMed  Google Scholar 

de Azevedo Medeiros LB, Cândido Dantas VK, Craveiro Sarmento AS, Agnez-Lima LF, Meireles AL, Xavier Nobre TT, et al. High prevalence of Berardinelli-Seip congenital lipodystrophy in Rio Grande do Norte State, Northeast Brazil. Diabetol Metab Syndr. 2017;9:80.

Article  PubMed  PubMed Central  Google Scholar 

Treiber G, Guilleux A, Huynh K, Bonfanti O, Flaus-Furmaniuk A, Couret D, et al. Lipoatrophic diabetes in familial partial lipodystrophy type 2: from insulin resistance to diabetes. Diabetes Metab. 2023;49:101409.

Article  CAS  PubMed  Google Scholar 

Kallali W, Messiaen C, Saïdi R, Lessim S, Viaud M, Dulon J, et al. Age at diagnosis in patients with chronic congenital endocrine conditions: a regional cohort study from a reference center for rare diseases. Orphanet J Rare Dis. 2021;16:469.

Article  PubMed  PubMed Central  Google Scholar 

Bonne G, Pouget J. [Diagnostic odyssey at the heart of the 3rd National Initiative for Rare disorders]. Med Sci MS. 2018;34(Hors s–rie n–2):5.

Google Scholar 

Jannot A-S, Messiaen C, Khatim A, Pichon T, Sandrin A. BNDMR infrastructure team. The ongoing French BaMaRa-BNDMR cohort: implementation and deployment of a nationwide information system on rare disease. J Am Med Inf Assoc. 2022;29:553–8.

Article  Google Scholar 

Maaroufi M, Landais P, Messiaen C, Jaulent M-C, Choquet R. Federating patients identities: the case of rare diseases. Orphanet J Rare Dis. 2018;13:199.

Article  PubMed  PubMed Central  Google Scholar 

Mosbah H, Donadille B, Vatier C, Janmaat S, Atlan M, Badens C, et al. Dunnigan lipodystrophy syndrome: French National diagnosis and care protocol (PNDS; Protocole National De Diagnostic et de soins). Orphanet J Rare Dis. 2022;17:170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yildirim Simsir I, Tuysuz B, Ozbek MN, Tanrikulu S, Celik Guler M, Karhan AN, et al. Clinical features of generalized lipodystrophy in Turkey: a cohort analysis. Diabetes Obes Metab. 2023;25:1950–63.

Article  PubMed  Google Scholar 

Corvillo F, Abel BS, López-Lera A, Ceccarini G, Magno S, Santini F, et al. Characterization and Clinical Association of Autoantibodies against Perilipin 1 in patients with acquired generalized Lipodystrophy. Diabetes. 2023;72:71–84.

Article  CAS  PubMed  Google Scholar 

Mandel-Brehm C, Vazquez SE, Liverman C, Cheng M, Quandt Z, Kung AF, et al. Autoantibodies to Perilipin-1 define a subset of Acquired Generalized Lipodystrophy. Diabetes. 2023;72:59–70.

Article  CAS  PubMed  Google Scholar 

Ceccarini G, Magno S, Gilio D, Pelosini C, Santini F. Autoimmunity in lipodystrophy syndromes. Presse Medicale Paris Fr 1983. 2021;50:104073.

Google Scholar 

Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, et al. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primer. 2020;6:48.

Article  Google Scholar 

Lemaitre M, Chevalier B, Jannin A, Bourry J, Espiard S, Vantyghem M-C. Multiple symmetric and multiple familial lipomatosis. Presse Medicale Paris Fr. 1983. 2021;50:104077.

Mosbah H, Vantyghem M-C, Nobécourt E, Andreelli F, Archambeaud F, Bismuth E, et al. Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: real-life experience from a national reference network. Diabetes Obes Metab. 2022;24:1565–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araújo-Vilar D, Loidi L, Domínguez F, Cabezas-Cerrato J. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2003;35:29–35.

Article  Google Scholar 

Vigouroux C, Magré J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000;49:1958–62.

Article  CAS  PubMed  Google Scholar 

Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 2000;85:1776–82.

CAS  PubMed  Google Scholar 

Adams C, Stears A, Savage D, Deaton C. We’re stuck with what we’ve got: the impact of lipodystrophy on body image. J Clin Nurs. 2018;27:1958–68.

Article  PubMed  Google Scholar 

Vatier C, Kalbasi D, Vantyghem M-C, Lascols O, Jéru I, Daguenel A, et al. Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes. Orphanet J Rare Dis. 2019;14:177.

Article  PubMed  PubMed Central  Google Scholar 

Huang-Doran I, Kinzer AB, Jimenez-Linan M, Thackray K, Harris J, Adams CL, et al. Ovarian hyperandrogenism and response to Gonadotropin-releasing hormone analogues in primary severe insulin resistance. J Clin Endocrinol Metab. 2021;106:2367–83.

Article  PubMed  PubMed Central  Google Scholar 

Vatier C, Christin-Maitre S, Vigouroux C. Role of insulin resistance on fertility - focus on polycystic ovary syndrome. Ann Endocrinol. 2022;83:199–202.

Article  Google Scholar 

Vasandani C, Li X, Sekizkardes H, Brown RJ, Garg A. Phenotypic differences among familial partial Lipodystrophy due to LMNA or PPARG variants. J Endocr Soc. 2022;6:bvac155.

Article  PubMed  PubMed Central  Google Scholar 

Lazarte J, Wang J, McIntyre AD, Hegele RA. Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2. J Clin Lipidol. 2021;15:653–7.

Article  PubMed  Google Scholar 

Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care. 2003;26:1350–5.

Article  CAS  PubMed  Google Scholar 

Mosbah H, Vatier C, Andriss B, Belalem I, Delemer B, Janmaat S, et al. Patients’ perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy. Eur J Endocrinol. 2024;190:23–33.

Article  PubMed  Google Scholar 

Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V. General Practice Care for patients with Rare diseases in Belgium. A cross-sectional survey. Int J Environ Res Public Health. 2018;15:1180.

Article  PubMed  PubMed Central  Google Scholar 

Simpson A, Bloom L, Fulop NJ, Hudson E, Leeson-Beevers K, Morris S, et al. How are patients with rare diseases and their carers in the UK impacted by the way care is coordinated? An exploratory qualitative interview study. Orphanet J Rare Dis. 2021;16:76.

Article  PubMed  PubMed Central  Google Scholar 

Soussand L, Kuchenbuch M, Messiaen C, Sandrin A, Jannot A-S, Nabbout R. Impact of the COVID-19 pandemic on the care of rare and undiagnosed diseases patients in France: a longitudinal population-based study. Orphanet J Rare Dis. 2022;17:430.

Article  PubMed  PubMed Central  Google Scholar 

von Schnurbein J, Adams C, Akinci B, Ceccarini G, D’Apice MR, Gambineri A, et al. European lipodystrophy registry: background and structure. Orphanet J Rare Dis. 2020;15:17.

Article  Google Scholar